| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/06/1991 | EP0411135A1 Dna fragments related to human immunoglobulin genes and method of diagnosis using said fragments |
| 02/06/1991 | EP0411031A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 02/06/1991 | EP0411018A1 Detection, quantitation and classification of ras proteins in body fluids and tissues. |
| 02/05/1991 | WO1991002080A2 Monoclonal antibody to acetylated lysine residues in recombinant bovine somatotropin |
| 02/05/1991 | WO1991001753A1 Inhibition of tumor growth by blockade of the protein c system |
| 02/05/1991 | US4990454 YH206 cell line and monoclonal antibody produced by it |
| 02/03/1991 | CA2022270A1 Process for the labeling of proteins or polypeptides with technetium-99m, conjugate thus obtained, use as imaging agent, kit for the reconstitution of these conjugates |
| 02/01/1991 | CA2022273A1 Chimeric antibodies directed against a human glycoprotein antigen |
| 01/31/1991 | DE3923951A1 Verfahren zum nachweis von leberzirrhose A method for detecting liver cirrhosis |
| 01/30/1991 | EP0410813A1 Anti-human BCDF monoclonal antibody and immunoassay using the same |
| 01/30/1991 | EP0410713A1 Polypeptide inhibitor of viral replication |
| 01/30/1991 | EP0410303A1 Monoclonal antibody to endothelin-3 or precursor thereof and use thereof |
| 01/30/1991 | EP0410272A1 Process for preparing an immunoglobulin preparation from colostrum |
| 01/30/1991 | EP0410246A1 Erythropoietin(EPO)-peptides and antibodies against them |
| 01/30/1991 | EP0410207A2 Stabilization of highly purified proteins |
| 01/30/1991 | EP0410147A1 Modified VP1/P2A regions of rhinovirus systems |
| 01/30/1991 | EP0410004A1 Immunoassay of human osteocalcin, reagent and kit therefor |
| 01/30/1991 | EP0409963A1 Immunoassay for fast homoarginine-sensitive alkaline phosphatase (fhap) and antibody useful therewith |
| 01/30/1991 | EP0409901A1 Lak cell cytotoxin |
| 01/30/1991 | EP0177531B1 Antibodies, manufacture and use |
| 01/29/1991 | CA2022185A1 Separation of anti-metal chelate antibodies |
| 01/29/1991 | CA1279592C Nortriptyline conjugates to antigenic proteins and enzymes |
| 01/28/1991 | CA2022146A1 Immunosuppressive monoclonal antibodies, hybridomas and methods of transplantation |
| 01/27/1991 | WO1991001990A1 Chimeric anti-cea antibody |
| 01/26/1991 | WO1991001329A1 Polypeptide inhibitor of viral replication |
| 01/26/1991 | WO1991001145A1 Pokeweed antiviral protein - monoclonal antibody conjugates |
| 01/26/1991 | CA2063801A1 Polypeptide inhibitor of viral replication |
| 01/26/1991 | CA2021739A1 Immunostimulating proteins, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas for uses in therapy and diagnosis |
| 01/25/1991 | CA2021452A1 Stabilization of highly purified proteins |
| 01/24/1991 | WO1991000921A1 Fragments of monoclonal antibodies specific to the presence of activated leucocytes, process for obtaining them and their application in the case of a transplant being rejected |
| 01/24/1991 | WO1991000919A1 Promoters of colony stimulating factor activity |
| 01/24/1991 | WO1991000916A2 Receptors for fibroblast growth factors |
| 01/24/1991 | WO1991000914A1 Production of antigens by self-assembly of polypeptide components |
| 01/24/1991 | WO1991000907A1 Monocyte chemotactic proteins and related peptides |
| 01/24/1991 | WO1991000906A1 Chimeric and transgenic animals capable of producing human antibodies |
| 01/24/1991 | WO1991000737A1 Treatment of obesity and essential hypertension and related disorders |
| 01/24/1991 | WO1990014881A3 Chelating agents for attaching metal ions to proteins |
| 01/24/1991 | CA2075896A1 Production of antigens by self-assembly of polypeptide components |
| 01/24/1991 | CA2035861A1 Promoters of colony stimulating factor activity |
| 01/23/1991 | EP0409607A2 Antibody to human interleukin-6 receptor |
| 01/23/1991 | EP0409472A1 Bone morphogenetic protein |
| 01/23/1991 | EP0409242A1 Monoclonal antibody against human CD4 peptide |
| 01/23/1991 | EP0409212A2 Stabilization of analytes |
| 01/23/1991 | EP0409091A1 Antagonists of GM-CSF derived from the carboxyl terminus |
| 01/23/1991 | EP0409040A1 Antibodies to Promoters of colony stimulating factor activity |
| 01/23/1991 | EP0408859A2 Monoclonal antibodies to activated endothelial cells |
| 01/23/1991 | EP0408625A1 Diagnosis of mycobacterium bovis infection. |
| 01/23/1991 | EP0387276A4 Method to produce immunodiagnostic reagents |
| 01/23/1991 | EP0302928B1 Inorganic filtration membrane modified for protein separation |
| 01/23/1991 | EP0183780B1 Distinguishing subsets of human cells |
| 01/22/1991 | WO1991002002A1 Recombinantly produced human membrane cofactor protein (mcp) |
| 01/22/1991 | CA1279276C Polypeptides and antibiotics characteristic of papillomavirus and use for the in vitro diagnostic, the prevention and/or the control of papillomavirus infections |
| 01/20/1991 | CA2021430A1 Stabilization of analytes |
| 01/20/1991 | CA2020729A1 Bone morphogenetic protein |
| 01/17/1991 | DE4020211A1 New rhinoviral DNA with mutation(s) in protease 2A region - and corresponding oligo:nucleotide(s) and oligopeptide(s), useful in test systems and as therapeutic competitive inhibitors |
| 01/16/1991 | EP0408294A2 Use of an amylin antagonist for the manufacture of amedicament for the treatment of obesity and essential hypertension and related disorders |
| 01/16/1991 | EP0408178A1 Immobilized protein G variants and the use thereof |
| 01/16/1991 | EP0408157A1 Acid-cleavable compound |
| 01/16/1991 | EP0408029A1 Method of fractionating plasma protein |
| 01/16/1991 | EP0407897A1 Compounds of biopolymers effector substances bonded together by optically active aminoacidic derivatives, process for their preparation and their use |
| 01/16/1991 | EP0407813A2 Oxidative denaturation of protein analytes |
| 01/16/1991 | EP0407586A1 Human monoclonal antibody and process for its preparation |
| 01/16/1991 | EP0407543A1 Mammalian gap-43 compositions and methods of use |
| 01/16/1991 | EP0407462A1 Dna binding proteins including androgen receptor |
| 01/16/1991 | EP0407451A1 General cancer-associated scm-recognition factor, preparation and method of use |
| 01/16/1991 | EP0407430A1 Therapeutic murine monoclonal antibody |
| 01/16/1991 | EP0407399A1 Immunosupression with anti-pan t-cell immunotoxin compositions |
| 01/16/1991 | EP0198086B1 Mouse human hybridoma producing antivirus human antibody, process for its preparation, and antivirus human monoclonal antibody |
| 01/15/1991 | WO1991001330A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/15/1991 | US4985362 Process of purifying tPA |
| 01/15/1991 | US4985352 DNA encoding serotonin 1C (5HT1c) receptor, isolated 5HT1c receptor, mammalian cells expressing same and uses thereof |
| 01/15/1991 | CA2062975A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/12/1991 | CA2019893A1 Method of fractionating plasma protein |
| 01/11/1991 | CA2020786A1 Treatment of obesity and essential hypertension and related disorders |
| 01/11/1991 | CA2020768A1 Compounds from biopolymers and effector substances which are linked via optically active amino acid derivatives, processes for the preparation thereof and the use thereof |
| 01/10/1991 | WO1991000519A1 Vitamin b12 assay |
| 01/10/1991 | WO1991000360A1 Bispecific reagents for aids therapy |
| 01/10/1991 | WO1991000354A1 Nucleic acid coding for the human testicular angiotensin conversion enzyme (eca) and its applications, in particular for the in vitro detection of said enzyme in the organism |
| 01/10/1991 | WO1991000351A1 Fungal stress proteins |
| 01/10/1991 | WO1991000349A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 01/10/1991 | WO1991000348A1 Modified vp1/p2a regions of the rhinoviral system |
| 01/10/1991 | WO1991000340A1 Antibody to p. falciparum antigen and hybridoma for making same |
| 01/10/1991 | WO1991000295A1 Novel antibodies reactive with human carcinomas |
| 01/10/1991 | WO1991000294A1 Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates |
| 01/10/1991 | WO1991000292A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/10/1991 | WO1991000289A2 Targeted liposomes and methods for liposome-protein coupling |
| 01/10/1991 | WO1991000100A2 Toxin uses |
| 01/10/1991 | WO1991000045A1 Reagents for detecting siv and hiv-2 |
| 01/10/1991 | WO1990014427A3 Multivalent repressor of gene function |
| 01/10/1991 | WO1990014069A3 Keratinocyte autocrine factor |
| 01/10/1991 | WO1990013643A3 Glycoprotein hormone receptor molecules |
| 01/10/1991 | WO1990012807A3 Purified, highly specific antibodies against gene products including retinoblastoma and method |
| 01/10/1991 | CA2062795A1 Bispecific reagents for aids therapy |
| 01/10/1991 | CA2059131A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/09/1991 | EP0407259A1 Hybrid proteins between an extracytoplasmic enzyme and at least another protein, preparation and method and application therefor |
| 01/09/1991 | EP0407230A1 Sporozoite and liver-stage protein antigen of P. falciparum |
| 01/09/1991 | EP0407122A1 Novel modified PF4 compositions and methods of use |
| 01/09/1991 | EP0407092A1 Lymphocyte-activating factor, method for the preparation thereof and method for the proliferation of antibody-forming lymphocytes and production of antibody using the same |
| 01/09/1991 | EP0406880A2 Method for stimulating macrophage activity against tumors and composition therefor |
| 01/09/1991 | EP0406857A1 Proteins and production thereof |